Finasteride topical - Acrux

Drug Profile

Finasteride topical - Acrux

Alternative Names: Finasteride MDTS

Latest Information Update: 02 Feb 2011

Price : $50

At a glance

  • Originator Acrux
  • Class Androstenes; Antiacnes; Antiandrogens; Antineoplastics; Azasteroids; Small molecules
  • Mechanism of Action Cholestenone 5-alpha reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Alopecia

Most Recent Events

  • 02 Feb 2011 Discontinued - Preclinical for Alopecia in Australia (Topical)
  • 02 Feb 2011 Discontinued - Preclinical for Alopecia in USA (Topical)
  • 23 May 2005 Acrux and Napa Biosciences have entered into an exclusive worldwide licensing agreement to develop and commercialise certain prescription and over-the-counter dermatology products for various skin disorders, including alopecia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top